Acceptability and readiness to promote human papillomavirus vaccination at ages 9–10 years: a feasibility study among North Carolina clinics

While 9-valent human papillomavirus (HPV) vaccination is approved by the US Food and Drug Administration for use in adolescents as young as age 9, providers typically recommend it at ages 11–12. Studies suggest that recommending HPV vaccination at 9 or 10 years of age could increase up-to-date vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Vielot, Nadja A., Lane, Robyn M., Loefstedt, Kaitlyn, Cunningham, Jennifer L., Everson, Jason, Tiller, Eli, Johnson Patel, Sarah E., Smith, Jennifer S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470204/
https://www.ncbi.nlm.nih.gov/pubmed/37653458
http://dx.doi.org/10.1186/s40814-023-01379-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470204/
https://www.ncbi.nlm.nih.gov/pubmed/37653458
http://dx.doi.org/10.1186/s40814-023-01379-y

Ejemplares similares